
Please contact the doctor's office to verify that your insurance is accepted.
Dr. Laurence is Professor of Medicine in the Division of Hematology-Oncology, Attending Physician at New York Presbyterian Hospital, and Director of the Laboratory for AIDS Virus Research at those institutions. He is also Senior Scientific Consultant for Programs at amfAR, The Foundation for AIDS Research, and Editor-in-Chief of two medical journals: AIDS Patient Care and STDs (in its 24th year), and Translational Research (formerly the Journal of Laboratory and Clinical Medicine, in its 96th year).
Dr. Laurence received his B.A. Phi Beta Kappa, summa cum laude from Columbia University in 1972, and his M.D. with honors from the University of Chicago Pritzker School of Medicine in 19...
Aging and AIDS: A Need for Focus on Neurodegenerative Diseases and the Broad Benefits of Such Research.
SGLT2 inhibitor dapagliflozin attenuates HIV-associated cardiac fibrosis, steatosis and diastolic dysfunction in a mouse model via inhibition of TGFβ signaling.
Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGF-β1 signaling.